The weekly litigation news digest is live. Subscribe now

IP Verse

A Cell Mediated Immune Response Assay With Enhanced Sensitivity - EP2726883

The patent EP2726883 was granted to Cellestis on May 18, 2022. The application was originally filed on Jun 27, 2012 under application number EP12804281A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2726883

CELLESTIS
Application Number
EP12804281A
Filing Date
Jun 27, 2012
Status
Patent Maintained As Amended
Apr 15, 2022
Publication Date
May 18, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOMERIEUXDec 27, 2018CABINET BEAU DE LOMENIEADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2012AU00420
DESCRIPTIONUS4016043
DESCRIPTIONUS4018653
DESCRIPTIONUS4424279
DESCRIPTIONWO2005118629
INTERNATIONAL-SEARCH-REPORTWO2009121845
OPPOSITIONEP1723426
OPPOSITIONUS2004141985
OPPOSITIONWO2009121845
OTHERWO2009121845
OTHERWO2011075773
SEARCHWO2009121845
SEARCHWO2011075773

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents